SARTORIUS AG-VORZUG (SRT3.DE) Stock Fundamental Analysis
Europe - FRA:SRT3 - DE0007165631
230.3 EUR
+0.1 (+0.04%)
We assign a fundamental rating of 3 out of 10 to SRT3. SRT3 was compared to 19 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of SRT3 have multiple concerns. SRT3 is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
SRT3 had positive earnings in the past year.
In the past year SRT3 had a positive cash flow from operations.
SRT3 had positive earnings in each of the past 5 years.
In the past 5 years SRT3 always reported a positive cash flow from operatings.
1.2 Ratios
SRT3 has a Return On Assets of 1.39%. This is in the lower half of the industry: SRT3 underperforms 73.68% of its industry peers.
Looking at the Return On Equity, with a value of 5.01%, SRT3 is doing worse than 68.42% of the companies in the same industry.
With a Return On Invested Capital value of 4.71%, SRT3 is not doing good in the industry: 73.68% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for SRT3 is in line with the industry average of 8.08%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROIC | 4.71% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
The Profit Margin of SRT3 (3.80%) is worse than 73.68% of its industry peers.
In the last couple of years the Profit Margin of SRT3 has declined.
The Operating Margin of SRT3 (14.06%) is worse than 68.42% of its industry peers.
In the last couple of years the Operating Margin of SRT3 has declined.
SRT3 has a better Gross Margin (46.48%) than 73.68% of its industry peers.
In the last couple of years the Gross Margin of SRT3 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SRT3 is creating some value.
Compared to 1 year ago, SRT3 has more shares outstanding
The number of shares outstanding for SRT3 has been increased compared to 5 years ago.
The debt/assets ratio for SRT3 has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.36 indicates that SRT3 is not a great score, but indicates only limited risk for bankruptcy at the moment.
SRT3 has a Altman-Z score of 2.36. This is comparable to the rest of the industry: SRT3 outperforms 42.11% of its industry peers.
The Debt to FCF ratio of SRT3 is 8.92, which is on the high side as it means it would take SRT3, 8.92 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of SRT3 (8.92) is worse than 68.42% of its industry peers.
SRT3 has a Debt/Equity ratio of 1.28. This is a high value indicating a heavy dependency on external financing.
SRT3's Debt to Equity ratio of 1.28 is on the low side compared to the rest of the industry. SRT3 is outperformed by 89.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Altman-Z | 2.36 |
ROIC/WACC0.6
WACC7.88%
2.3 Liquidity
SRT3 has a Current Ratio of 0.95. This is a bad value and indicates that SRT3 is not financially healthy enough and could expect problems in meeting its short term obligations.
SRT3 has a Current ratio of 0.95. This is amonst the worse of the industry: SRT3 underperforms 89.47% of its industry peers.
A Quick Ratio of 0.49 indicates that SRT3 may have some problems paying its short term obligations.
SRT3 has a worse Quick ratio (0.49) than 94.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 59.34% over the past year.
The earnings per share for SRT3 have been decreasing by -11.87% on average. This is quite bad
Looking at the last year, SRT3 shows a small growth in Revenue. The Revenue has grown by 5.82% in the last year.
SRT3 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.10% yearly.
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
3.2 Future
SRT3 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.28% yearly.
The Revenue is expected to grow by 8.99% on average over the next years. This is quite good.
EPS Next Y22.69%
EPS Next 2Y21.53%
EPS Next 3Y21.2%
EPS Next 5Y19.28%
Revenue Next Year5.43%
Revenue Next 2Y6.87%
Revenue Next 3Y8.23%
Revenue Next 5Y8.99%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 50.50, the valuation of SRT3 can be described as expensive.
Based on the Price/Earnings ratio, SRT3 is valued expensively inside the industry as 84.21% of the companies are valued cheaper.
Compared to an average S&P500 Price/Earnings ratio of 25.89, SRT3 is valued quite expensively.
With a Price/Forward Earnings ratio of 38.05, SRT3 can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, SRT3 is valued expensively inside the industry as 84.21% of the companies are valued cheaper.
When comparing the Price/Forward Earnings ratio of SRT3 to the average of the S&P500 Index (34.59), we can say SRT3 is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50.5 | ||
| Fwd PE | 38.05 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SRT3 is valued a bit more expensive than 63.16% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SRT3 is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.03 | ||
| EV/EBITDA | 22.79 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SRT3 does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as SRT3's earnings are expected to grow with 21.20% in the coming years.
PEG (NY)2.23
PEG (5Y)N/A
EPS Next 2Y21.53%
EPS Next 3Y21.2%
5. Dividend
5.1 Amount
SRT3 has a yearly dividend return of 0.40%, which is pretty low.
Compared to an average industry Dividend Yield of 0.76, SRT3 has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, SRT3's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
5.2 History
The dividend of SRT3 has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
SRT3 pays out 37.92% of its income as dividend. This is a sustainable payout ratio.
The dividend of SRT3 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP37.92%
EPS Next 2Y21.53%
EPS Next 3Y21.2%
FRA:SRT3 (11/14/2025, 5:36:15 PM)
230.3
+0.1 (+0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.24B
Revenue(TTM)3.52B
Net Income(TTM)133.70M
Analysts80
Price Target342.38 (48.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP37.92%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.85%
Min EPS beat(2)-10.52%
Max EPS beat(2)4.83%
EPS beat(4)1
Avg EPS beat(4)-3.47%
Min EPS beat(4)-10.52%
Max EPS beat(4)4.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)1.91%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.9%
PT rev (3m)0.72%
EPS NQ rev (1m)3.45%
EPS NQ rev (3m)3.45%
EPS NY rev (1m)-0.47%
EPS NY rev (3m)-0.17%
Revenue NQ rev (1m)2.71%
Revenue NQ rev (3m)2.71%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)-0.19%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50.5 | ||
| Fwd PE | 38.05 | ||
| P/S | 4.9 | ||
| P/FCF | 36.03 | ||
| P/OCF | 19.72 | ||
| P/B | 6.46 | ||
| P/tB | N/A | ||
| EV/EBITDA | 22.79 |
EPS(TTM)4.56
EY1.98%
EPS(NY)6.05
Fwd EY2.63%
FCF(TTM)6.39
FCFY2.78%
OCF(TTM)11.68
OCFY5.07%
SpS46.97
BVpS35.63
TBVpS-35.24
PEG (NY)2.23
PEG (5Y)N/A
Graham Number60.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROCE | 6.33% | ||
| ROIC | 4.71% | ||
| ROICexc | 4.98% | ||
| ROICexgc | 17.77% | ||
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% | ||
| FCFM | 13.61% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexgc growth 3Y-35.26%
ROICexgc growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Debt/EBITDA | 3.69 | ||
| Cap/Depr | 92.32% | ||
| Cap/Sales | 11.25% | ||
| Interest Coverage | 2.65 | ||
| Cash Conversion | 94.72% | ||
| Profit Quality | 357.97% | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 | ||
| Altman-Z | 2.36 |
F-Score7
WACC7.88%
ROIC/WACC0.6
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
EPS Next Y22.69%
EPS Next 2Y21.53%
EPS Next 3Y21.2%
EPS Next 5Y19.28%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
Revenue Next Year5.43%
Revenue Next 2Y6.87%
Revenue Next 3Y8.23%
Revenue Next 5Y8.99%
EBIT growth 1Y18.65%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year99.69%
EBIT Next 3Y38.21%
EBIT Next 5Y26.8%
FCF growth 1Y123.33%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y6.61%
OCF growth 3Y4.07%
OCF growth 5Y20.79%
SARTORIUS AG-VORZUG / SRT3.DE FAQ
What is the ChartMill fundamental rating of SARTORIUS AG-VORZUG (SRT3.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE.
What is the valuation status for SRT3 stock?
ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS AG-VORZUG (SRT3.DE). This can be considered as Overvalued.
Can you provide the profitability details for SARTORIUS AG-VORZUG?
SARTORIUS AG-VORZUG (SRT3.DE) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for SRT3 stock?
The Price/Earnings (PE) ratio for SARTORIUS AG-VORZUG (SRT3.DE) is 50.5 and the Price/Book (PB) ratio is 6.46.
What is the expected EPS growth for SARTORIUS AG-VORZUG (SRT3.DE) stock?
The Earnings per Share (EPS) of SARTORIUS AG-VORZUG (SRT3.DE) is expected to grow by 22.69% in the next year.